Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations
Authors
Keywords
-
Journal
JOURNAL OF HUMAN GENETICS
Volume 60, Issue 9, Pages 539-545
Publisher
Springer Nature
Online
2015-06-25
DOI
10.1038/jhg.2015.61
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form
- (2013) Mohammad Arif Hossain et al. GENE
- A high-throughput screening assay using Krabbe disease patient cells
- (2012) Jameson Ribbens et al. ANALYTICAL BIOCHEMISTRY
- Therapeutic chaperone effect of N-Octyl 4-Epi-β-valienamine on murine GM1-gangliosidosis
- (2012) Yoshiyuki Suzuki et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological chaperone therapy for Fabry disease
- (2012) Satoshi ISHII PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide
- (2011) Omid Motabar et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
- (2011) Katsumi Higaki et al. HUMAN MUTATION
- Biochemical and structural study on a S529V mutant acid α-glucosidase responsive to pharmacological chaperones
- (2011) Youichi Tajima et al. JOURNAL OF HUMAN GENETICS
- Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors with Chaperone Activity
- (2011) Juan J. Marugan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insights into Krabbe disease from structures of galactocerebrosidase
- (2011) J. E. Deane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
- (2010) W. C. Lee et al. JOURNAL OF NEUROSCIENCE
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular interaction of imino sugars with human α-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease
- (2009) Kanako Sugawara et al. MOLECULAR GENETICS AND METABOLISM
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search